Literature DB >> 8025918

Direct recording of EDP-EDV relationship in isolated rat left ventricle: effect of diastolic crossbridge formation.

P Schiereck1, R Hoefnagel, E L De Beer, B G Van Heijst, W L Mosterd.   

Abstract

OBJECTIVE: The aim was to investigate whether the end diastolic pressure-end diastolic volume (EDP-EDV) relationship of the left ventricle can be influenced by calcium dependent elements, especially at low values of end diastolic pressure.
METHODS: Isolated rat hearts were perfused in a modified Langendorff perfusion system. The EDP-EDV relationship of the left ventricle was investigated. Pressure was recorded with a microtip pressure catheter and volume with a microconductance catheter. Crossbridge cycling was affected by adding calcium antagonists (verapamil, diltiazem, nifedipine at 2.10(-7) M) or by adding the Mg-ATPase blocker BDM (2,3-butanedione-2-monoxime, 10(-3) M) to the perfusate.
RESULTS: The above had a negative inotropic effect in systole. At EDP = 0 after stimulation the active isovolumetric pressure was zero. In diastole, BDM shifted the EDP-EDV relationship to slightly smaller EDVs. A decrease of about 5% in the EDV was found at lower EDP values. Ca2+ antagonists increased the EDV up to 40-80% at low EDP values. At higher EDP values only a small increase of EDV (about 10%) was found after verapamil perfusion. The results obtained are interpreted in terms of a three step crossbridge model.
CONCLUSIONS: At low EDP, diastolic volume is dependent upon weakly bound crossbridges as a function of the [Ca2+] in the cardiac cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025918     DOI: 10.1093/cvr/28.5.715

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  1 in total

1.  A common mechanism for concurrent changes of diastolic muscle length and systolic function in intact hearts.

Authors:  L Lu; Y Xu; P Zhu; C Greyson; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.